A cooperative’s delivery records could become more useful to investors when separate buyers report comparable results. The first test is whether that evidence answers a real financing question.

A cooperative delivers its product. A buyer checks the quality and accepts the shipment. That transaction creates evidence of a business doing what it promised. Could a second buyer’s experience make that evidence more useful to an investor?

Indonesia’s bioeconomy financing challenge gives the question a practical setting. Reporting from the Indonesia Impact Investment Summit on 21 October 2026, ANTARA described Bappenas’s concerns about project readiness: permits, land legality, raw materials, financing risk, market access and traceability. It also reported the launch of the Indonesia Bioeconomy Finance Lab, a collaboration space connecting businesses with funders. ANTARA’s report

Better delivery evidence would address only part of that problem. It could nevertheless be worth testing where a fund already sees a plausible business but needs a clearer picture of its ability to supply customers consistently.

A financing gap with several causes

The Indonesia Impact Alliance’s 2024 landscape study estimated an annual financing gap of US$50.8 billion for Indonesia’s “missing middle” impact enterprises. This covers a broader group than bioeconomy businesses. Among its 51 surveyed entrepreneurs, 55% intended to raise US$100,000–US$1 million; most interviewed impact-oriented funds expected primarily to invest at least US$1 million, while allowing some smaller investments. IIA landscape report, pages 4, 9 and 20

These findings point to a mismatch in funding sizes as well as the work of preparing businesses for investment. A delivery dashboard cannot fix an unsuitable investment structure, weak margins or an unresolved land claim. The narrower opportunity is to help a business present customer evidence that an investment team can examine and compare.

Multiply the check, preserve the transaction

The proposed experiment applies Multiplication, a Systematic Inventive Thinking tool: copy an existing component, then change something about the copy. Here, the component is the buyer’s quality check. The changed component is a check by another buyer, using agreed measurements and submitting its findings separately.

Two buyers would purchase separate portions of one identified production lot from a participating cooperative. Each would inspect the portion it actually receives and record its own quantity, quality measurements and acceptance decision. Both portions would link back to the parent lot, while retaining distinct shipment identifiers.

For example, imagine a 500-kilogram lot split into a 200-kilogram shipment for Buyer A and a 300-kilogram shipment for Buyer B. Each buyer confirms only its own receipt. If both portions meet the agreed quality specification, their records provide two observations associated with that lot. The quantities differ; nobody counts the same goods twice. These numbers illustrate the proposed design.

The hypothesis is that comparable observations from separate customers could help a fund assess supply consistency better than an isolated testimonial. Agreement would still be limited evidence: it would say something about those portions at those inspection times. It would not establish the quality of every unit in the lot or guarantee future deliveries.

Give the fund a question before building a dashboard

A trade association, cooperative service organisation or other neutral operator could coordinate the trial. It would first ask a participating investment team which unresolved question the records might answer—for example, whether a cooperative repeatedly supplies a specified grade to more than one customer.

The operator, buyers and cooperative would then agree on comparable tests, inspection timing, lot identification and how to record rejected or disputed deliveries. Buyers would submit their findings without seeing the other buyer’s result. The fund and authorised operator could examine both records; buyers would not need access to each other’s procurement data.

A simple form and controlled spreadsheet could support an initial test. Each entry would retain its submitter, timestamp, supporting document references and correction history. Receipts and dispatch records would help check the link between the parent lot and its shipments. Without a credible link, two entries would remain two unrelated observations.

The operator would preserve disagreements. Different results could reveal uneven production, handling damage or incompatible testing methods. A dashboard that hides those differences would undermine the evidence it is supposed to improve.

What is different from existing tools?

Shared supply-chain records already exist. GS1’s EPCIS standard enables businesses to exchange information about product movements, status and custody. Buyer confirmation also already supports finance: IFC’s Global Trade Supplier Finance programme purchases receivables accepted for payment by approved buyers. GS1 EPCIS; IFC supplier finance

The proposed experiment combines comparable quality observations from two customers with a fund’s review of a cooperative’s supply performance. It is an evidence service, with no capital pool or automatic lending trigger. Its value would have to come from answering a financing question that ordinary receipts, customer references or existing traceability records leave unresolved. The research does not establish that this combination is unprecedented.

Who might pay?

A fund’s technical-assistance programme, a development partner or a trade association could sponsor the initial coordination. Possible continuing revenue would come from preparing and maintaining evidence packages that investment teams find useful.

That payer hypothesis remains untested. Costs would include record collection, buyer participation, lot reconciliation, quality-test alignment and fund review. If gathering the evidence costs more than the work it saves, or adds little to existing checks, there may be no viable service. A useful pilot would record staff time and direct costs alongside the delivery results.

A small test with a clear stopping point

An illustrative trial could involve two unrelated buyers, up to four cooperatives and ten production lots in one commodity in Java, over eight to twelve weeks. Each included lot would need genuine sales of separate portions to both buyers. Before starting, the operator would allocate the intended lots per cooperative, allowing repeated observations wherever it plans to assess consistency over time. It would report selected lots, actual shipments and completed buyer records separately, retaining missing records, disagreements and withdrawals. Results would show each cooperative’s lot count, so that a single observation cannot imply repeated performance and only successful deliveries do not determine the result. These are proposed pilot parameters, not source-derived benchmarks.

Before collection begins, the participating fund would specify the question it wants answered and what would make a record usable. After collection, its reviewer would assess the package alongside the usual business documents and explain which records it used, what they contributed and what remained unresolved. An expression of interest alone would not show that the evidence affected an assessment.

The trial would justify a larger test if the records can be collected credibly and the investment team identifies a specific contribution to its review. It should stop or change direction if lot links cannot be checked, buyers cannot produce comparable measurements, participation requires uneconomic extra purchases, or the fund finds no additional value.

Ten lots and one fund would provide an early feasibility signal. They would not establish lower default risk, faster due diligence or greater access to capital. Those outcomes would need subsequent comparisons with ordinary practice.

Where the idea could fail

Separate buyers can share incentives, coordinate answers or rely on the same flawed test. Independent submission would reduce copying opportunities without proving independence or truth. Lot reconciliation and spot checks could expose some errors; they would not eliminate fraud or sampling limitations.

Commercial confidentiality also matters. The operator would minimise collected data, restrict access and obtain appropriate advice on the proposed sharing arrangement before starting. Excluding prices would not by itself settle confidentiality, competition or privacy questions. The project’s legal position has not been assessed.

Most fundamentally, a record of accepted deliveries cannot create future orders, prove payment, establish environmental impact or make a weak business profitable. The useful result would be more modest: an investor can identify which customer observations it trusts, what those observations show and what still needs investigation.

That is the question worth testing: can routine checks by two customers become evidence that helps a bioeconomy business explain its performance to a fund?

Editorial and research notes

Final shared hypothesis

• Problem and actor: a bioeconomy cooperative seeking investment may have customer evidence that is difficult for an investment team to compare. Its prevalence and importance relative to other barriers are unverified.
• Intervention: two unrelated buyers inspect their separately purchased portions of a traceable parent lot using agreed measurements, submit separately, and allow controlled review by an operator and fund.
• Causal chain: real transactions plus credible lot links → comparable customer observations → fund can evaluate repeated supply performance → possible useful supplementary evidence. Improved financing access is a later hypothesis.
• Assumptions: genuine paired purchases are available; the commodity and portions permit meaningful comparisons; buyers participate; lot identity is credible; collection is affordable; the fund has a relevant unresolved question.
• Expected initial outcome: usable records and an investment reviewer’s specific explanation of their contribution or lack of contribution. No inference of financing approval, risk reduction or efficiency gains.
• Uncertainties: adoption, willingness to pay, independence, representativeness, incremental information, data permissions, legal position and economics. These remain explicit uncertainties rather than proof of invalidity.

Source verification

1. ANTARA, “Bappenas: Kesiapan proyek usaha kunci tarik investasi bioekonomi,” 21 October 2026, Aria Ananda. Located the original report and checked the project-readiness barriers and IBFL launch against it. The article paraphrases selectively and makes no claim that IBFL has agreed to participate. URL: https://www.antaranews.com/berita/5802629/bappenas-kesiapan-proyek-usaha-kunci-tarik-investasi-bioekonomi
2. IIA, Indonesian Impact Investment Wholesaler: Unlocking Indonesia’s Impact Investment Potential, July 2024. Read the primary report via TSIC-hosted PDF. Printed page 4 states 51 entrepreneur survey responses; page 9 gives the US$50.8 billion annual missing-middle estimate; page 20 gives 55% seeking US$100,000–US$1 million and the interviewed funds’ expected primary minimum of US$1 million with exceptions. Corrected the recovered article’s US$2 million upper bound. The report’s estimate is historical and broader than bioeconomy; it is not evidence that capital is idle or that missing records cause the entire gap. URL: https://site2025.tsiconsultancy.com/wp-content/uploads/2025/02/IIA_Landscape-Report-2024.pdf
3. GS1, EPCIS & CBV. Primary standards organisation describes interoperable supply-chain event sharing. Supports the existing-alternative discussion, not independent verification or fund acceptance. URL: https://www.gs1.org/standards/epcis
4. IFC, Global Trade Supplier Finance. Primary programme description explains financing against receivables accepted by approved buyers, based on buyer credit strength. Supports the existing-finance comparison, not the proposed two-buyer mechanism. URL: https://www.ifc.org/en/what-we-do/sector-expertise/trade-and-supply-chain-finance/global-trade-supplier-finance

Sources checked online on 22 October 2026. No interviews, pilot, legal assessment, market-wide novelty search occurred. No direct quotations remain in the final article. No claimed commercial outcome has been verified.